机构:[1]Hebei Provincial Center for Clinical Laboratories, The Second Hospital of Hebei Medical University, Shijiazhuang, China[2]Research Center, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China河北医科大学第四医院[3]Clinical Oncology Research Center, Shijiazhuang, China Key Laboratory of Tumor Gene Diagnosis, Prevention and Therapy[4]Clinical Oncology Research Center, Shijiazhuang, ChinaClinical Oncology Research Center, Shijiazhuang, China[5]Comprehensive Surgical Department, Hebei Provincial Hospital of Traditional Chinese Medicine, Shijiazhuang, China
第一作者机构:[1]Hebei Provincial Center for Clinical Laboratories, The Second Hospital of Hebei Medical University, Shijiazhuang, China
共同第一作者:
通讯作者:
通讯机构:[1]Hebei Provincial Center for Clinical Laboratories, The Second Hospital of Hebei Medical University, Shijiazhuang, China[*1]215 Hepingxi Road, Shijiazhuang City, Hebei Province, 050000, China.
推荐引用方式(GB/T 7714):
Li Zhirong,Ouyang Zirou,Zhang Huimin,et al.Novel target and PCR assay for identification of hypervirulent ST1 (BI/NAP1/027) Clostridioides difficile and detection of toxigenic C. Difficile[J].Clinica Chimica Acta; International Journal Of Clinical Chemistry.2024,559:119728.doi:10.1016/j.cca.2024.119728.
APA:
Li Zhirong,Ouyang Zirou,Zhang Huimin,Mi Chaoyi,Dong Ning...&Zhao Jianhong.(2024).Novel target and PCR assay for identification of hypervirulent ST1 (BI/NAP1/027) Clostridioides difficile and detection of toxigenic C. Difficile.Clinica Chimica Acta; International Journal Of Clinical Chemistry,559,
MLA:
Li Zhirong,et al."Novel target and PCR assay for identification of hypervirulent ST1 (BI/NAP1/027) Clostridioides difficile and detection of toxigenic C. Difficile".Clinica Chimica Acta; International Journal Of Clinical Chemistry 559.(2024):119728